Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    "Prurigo nodularis"
Show Display Options
Rank Status Study
1 Recruiting A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist VPD-737 Prurigo Nodularis (PN)
Condition: Prurigo Nodularis
Interventions: Drug: VPD-737;   Drug: Placebo
2 Not yet recruiting Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo
Interventions: Drug: nalbuphine HCl ER 90 mg BID;   Drug: nalbuphine HCl ER 120 mg BID;   Drug: nalbuphine HCl ER 180 mg BID
3 Not yet recruiting Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 90 mg BID;   Drug: nalbuphine HCl ER tablets 180 mg BID;   Drug: Placebo tablets BID
4 Completed
Has Results
Safety and Efficacy of CC-10004 for Prurigo Nodularis
Condition: Prurigo Nodularis
Intervention: Drug: CC-10004
5 Unknown  Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
Condition: Prurigo Nodularis
Intervention: Drug: citalopram (cipralex)
6 Completed Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
Condition: Prurigo Nodularis
Interventions: Drug: Pimecrolimus;   Drug: Hydrocortisone
7 Not yet recruiting Dapsone Prurigo Study
Condition: Lichen Simples Chronicus and Prurigo
Intervention: Drug: Dapsone gel - verum

Indicates status has not been verified in more than two years